EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dose Optimization Challenges of Colistin Sulfate in ICU Patients With Renal Dysfunction: A Population PK Modeling Approach

Shuting Zhang, Jing Ling, Yi Xu, Xuping Yang, Li’an Zuo, Liying Wang, Yang Deng, Nan Hu, Rong Chen

Journal of Clinical Pharmacy and Therapeutics · 2026-01 · 2026 (1)

DOI: 10.1155/jcpt/1196496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Pharmacy and Therapeutics, online erschienen am 24.05.2026. Verfasst von Shuting Zhang und 8 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To develop a population pharmacokinetic model for colistin sulfate in Chinese critically ill patients, identify factor multifactorial determinants of pharmacokinetic variability including extracorporeal support modalities, and establish a precision dosing framework guided by quantitative pharmacodynamic targets.

Methods

This study enrolled 59 critically ill adult patients with microbiological evidence of infection caused by carbapenem‐resistant Gram‐negative organisms and antimicrobial susceptibility or empirical treatment. A nonlinear mixed‐effects modeling (NONMEM) approach incorporating 278 concentration measurements was employed to characterize covariate effects, explicitly evaluating ECMO/CRRT impacts. Model robustness was validated through goodness‐of‐fit (GOF), bootstrap, normalized prediction distribution errors (NPDEs), and external clinical verification. Monte Carlo simulations were conducted to quantify target attainment probabilities for f AUC/MIC ≥ 20 under varying renal function and MIC scenarios (0.5∼2 mg·L −1 ).

Results

A one‐compartment model with first‐order elimination demonstrated superior fit, identifying creatinine clearance (CrCl) as the primary covariate influencing clearance. The integrated validation paradigm confirmed model reliability. The simulation revealed critical limitations of conventional dosing: 1.0∼1.5 MU a day is insufficient for patients with normal renal function or those infected with pathogens with an MIC ≥ 1.0 mg·L −1 . Therefore, the dosing regimen of colistin sulfate should be tailored according to renal function and the MIC.

Conclusion

To our knowledge, this study establishes the first PPK model integrating dynamic renal function and extracorporeal support effects for colistin sulfate in Chinese critically ill patients. The developed model‐to‐clinic pipeline, combining Monte Carlo simulation‐derived breakpoints and Bayesian forecasting, provides a paradigm for individualized antimicrobial dosing in complex critical care scenarios.

Zitieren

APA

Zhang, S., Ling, J., Xu, Y., Yang, X., Zuo, L., Wang, L., Deng, Y., Hu, N., & Chen, R. (2026). Dose Optimization Challenges of Colistin Sulfate in ICU Patients With Renal Dysfunction: A Population PK Modeling Approach. Journal of Clinical Pharmacy and Therapeutics, 2026(1). https://doi.org/10.1155/jcpt/1196496

Vancouver

Zhang S, Ling J, Xu Y, Yang X, Zuo L, Wang L, et al. Dose Optimization Challenges of Colistin Sulfate in ICU Patients With Renal Dysfunction: A Population PK Modeling Approach. Journal of Clinical Pharmacy and Therapeutics. 2026;2026(1). doi:10.1155/jcpt/1196496

BibTeX
@article{Zhang2026,
  author = {Zhang, Shuting and Ling, Jing and Xu, Yi and Yang, Xuping and Zuo, Li’an and Wang, Liying and Deng, Yang and Hu, Nan and Chen, Rong},
  title = {Dose Optimization Challenges of Colistin Sulfate in ICU Patients With Renal Dysfunction: A Population PK Modeling Approach},
  journal = {Journal of Clinical Pharmacy and Therapeutics},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jcpt/1196496}
}
Kostenlos starten →